RT Journal
A1 Bell J, Strandberg TE, Pitkälä KH
T1 USe of ppis are not associated with mortality in institutionalized older people—reply
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2011
FD May 9
VO 171
IS 9
SP 866
OP 867
DO 10.1001/archinternmed.2011.165
UL http://dx.doi.org/10.1001/archinternmed.2011.165
AB 
Twelve-month mortality among the residents of intermediate-level aged care facilities studied by Wilson and colleagues was 10.3% compared with 28.2% and 24.9% in our 2 cohorts.1 In addition to possible differences in organization of care, the lower mortality may attributed to the fact that residents were only eligible for inclusion in their falls prevention study if facility staff judged that they were likely to survive for 12 months.2 It is possible, therefore, that frail residents most susceptible to adverse drug events associated with PPIs were not included in the study.